Literature DB >> 1310216

Transcellular transport of organic cation across monolayers of kidney epithelial cell line LLC-PK.

H Saito1, M Yamamoto, K Inui, R Hori.   

Abstract

Transcellular transport and the accumulation of [14C]tetraethylammonium, a typical organic cation, by LLC-PK1 cell monolayers grown on microporous membrane filters were studied. Tetraethylammonium was accumulated progressively in the monolayers from the basolateral side and was transported unidirectionally to the apical side. The transcellular transport of tetraethylammonium was saturable, temperature dependent, and sensitive to the pH of the apical side of the monolayers. The apparent Michaelis constant and maximum velocity values for the transport were 67 microM and 222 pmol.mg protein-1.min-1, respectively. Unlabeled tetraethylammonium, amiloride, procainamide, cimetidine, and choline inhibited the basolateral uptake and transcellular transport of [14C]tetraethylammonium. The development of tetraethylammonium transport activity was observed in the differentiating cells. A sulfhydryl reagent inhibited the tetraethylammonium transport at both the basolateral and apical membranes of the LLC-PK1 cells. These findings suggest that these monolayers possess unidirectional transport systems for organic cations, corresponding to the secretion in the renal proximal tubules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310216     DOI: 10.1152/ajpcell.1992.262.1.C59

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Kinetic analysis of p-aminohippurate transport in the OK kidney epithelial cell line.

Authors:  Y Habu; I Yano; M Okuda; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

2.  Kinetic analysis of tetraethylammonium transport in the kidney epithelial cell line, LLC-PK1.

Authors:  Y Tomita; Y Otsuki; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid.

Authors:  Noboru Okamura; Shuichi Ohnishi; Hiroyuki Shimaoka; Ryo Norikura; Hiroshi Hasegawa
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.

Authors:  J Karlsson; S M Kuo; J Ziemniak; P Artursson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.

Authors:  Tomohiro Terada; Satohiro Masuda; Jun-Ichi Asaka; Masahiro Tsuda; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Contribution of ion-pair complexation with bile salts to the transport of organic cations across LLC-PK1 cell monolayers.

Authors:  Im-Sook Song; Yong-Hae Han; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

7.  Decreased cellular toxicity of neomycin in a clonal cell line isolated from LLC-PK1.

Authors:  R Hori; M Okuda; Y Ohishi; M Yasuhara; K Inui; M Takano
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

8.  Cellular toxicity of aminoglycoside antibiotics in G418-sensitive and -resistant LLC-PK1 cells.

Authors:  M Takano; M Okuda; M Yasuhara; R Hori
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

9.  pH-dependent transport of procainamide in cultured renal epithelial monolayers of OK cells: consistent with nonionic diffusion.

Authors:  A J Dudley; C D Brown
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3.

Authors:  Jun-ichi Asaka; Tomohiro Terada; Masahiro Okuda; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2006-03-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.